Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Updates to the study record page include the addition of key attribution details (Craig L Slingluff, Jr and University of Virginia) and new navigation/help links (How to Read a Study Record, Common Questions, How to Join a Study). It also shows changes to status verification labels (Last verified, Last known status was) and a new revision tag (Revision: v3.6.0).
    Difference
    1%
    Check dated 2026-06-12T16:00:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, signaling a small update to the page. The change appears to be a version bump without visible content edits.
    Difference
    0.1%
    Check dated 2026-06-05T12:23:07.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, representing a newer version of the page. It is a metadata/version update and does not reflect a substantive change to study content.
    Difference
    0.1%
    Check dated 2026-05-15T05:25:43.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page “Revision” from v3.5.2 to v3.5.3, reflecting a platform/version release rather than any change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:56:51.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:02.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no study details or outcomes appear to be affected.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.